Page last updated: 2024-09-03

n(6)-carboxymethyllysine and telmisartan

n(6)-carboxymethyllysine has been researched along with telmisartan in 1 studies

Compound Research Comparison

Studies
(n(6)-carboxymethyllysine)
Trials
(n(6)-carboxymethyllysine)
Recent Studies (post-2010)
(n(6)-carboxymethyllysine)
Studies
(telmisartan)
Trials
(telmisartan)
Recent Studies (post-2010) (telmisartan)
803443651,9304801,038

Protein Interaction Comparison

ProteinTaxonomyn(6)-carboxymethyllysine (IC50)telmisartan (IC50)
Cytochrome P450 2C9 Homo sapiens (human)0.42
Type-1 angiotensin II receptorHomo sapiens (human)0.0179
Type-2 angiotensin II receptorHomo sapiens (human)0.0003
Cytochrome P450 2J2Homo sapiens (human)0.5
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)1.2589
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)1.8621

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akizawa, T; Aoshima, Y; Hirai, Y; Honda, H; Hosaka, N; Michihata, T1

Trials

1 trial(s) available for n(6)-carboxymethyllysine and telmisartan

ArticleYear
Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2012, Volume: 34, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Arginine; Benzimidazoles; Benzoates; Blood Pressure; Female; Glycation End Products, Advanced; Humans; Hypertension, Renal; Imidazoles; Inflammation; Kidney Failure, Chronic; Lysine; Male; Olmesartan Medoxomil; Oxidative Stress; Pilot Projects; Prospective Studies; Renal Dialysis; Telmisartan; Tetrazoles; Treatment Outcome

2012